IMPACT SCORE JOURNAL RANKING CONFERENCE RANKING Conferences Journals Workshops Seminars SYMPOSIUMS MEETINGS BLOG LaTeX 5G Tutorial Free Tools

Search About Journals, Conferences, and Book Series

Therapeutic Advances in Drug Safety

Impact, Factor and Metrics, Impact Score, Ranking, h-index, SJR, Rating, Publisher, ISSN, and More

Last Updated on September 3, 2024

Impact Score

2023-2024

3.07

h-Index

2023-2024

 46

Rank

2023-2024

 4195

SJR

2023-2024

 1.035

Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.

Important Metrics and Factor

Title Therapeutic Advances in Drug Safety
Abbreviation Ther. Adv. Drug Saf.
Publication Type Journal
Subject Area, Categories, Scope Pharmacology (medical) (Q1)
h-index 46
Overall Rank/Ranking 4195
SCImago Journal Rank (SJR) 1.035
Impact Score 3.07
Publisher SAGE Publications Ltd
Country United Kingdom
ISSN 20420986, 20420994
Best Quartile Q1
Coverage History 2010-2023




About Therapeutic Advances in Drug Safety


Therapeutic Advances in Drug Safety is a journal covering the technologies/fields/categories related to Pharmacology (medical) (Q1). It is published by SAGE Publications Ltd. The overall rank of Therapeutic Advances in Drug Safety is 4195. According to SCImago Journal Rank (SJR), this journal is ranked 1.035. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 46. The best quartile for this journal is Q1.

The ISSN of Therapeutic Advances in Drug Safety journal is 20420986, 20420994. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Therapeutic Advances in Drug Safety is cited by a total of 396 articles during the last 3 years (Preceding 2023).


Therapeutic Advances in Drug Safety Impact IF 2023-2024


The Impact IF 2023 of Therapeutic Advances in Drug Safety is 3.07, which is computed in 2024 as per its definition. Therapeutic Advances in Drug Safety IF is decreased by a factor of 0.41 and approximate percentage change is -11.78% when compared to preceding year 2022, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.

Table Setting

Therapeutic Advances in Drug Safety Impact IF 2024 Prediction


Impact IF 2023 of Therapeutic Advances in Drug Safety is 3.07. If the same downward trend persists, Impact IF may fall in 2024 as well.


Impact IF Trend


Year wise Impact IF of Therapeutic Advances in Drug Safety. Based on Scopus data.


Year Impact IF
2023/2024 Coming Soon
2023 3.07
2022 3.48
2021 2.71
2020 3.39
2019 3.33
2018 2.76
2017 2.56
2016 5.77
2015 4.59
2014 1.06

Therapeutic Advances in Drug Safety h-index


  Table Setting

Therapeutic Advances in Drug Safety has an h-index of 46. It means 46 articles of this journal have more than 46 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.




Therapeutic Advances in Drug Safety ISSN


The ISSN of Therapeutic Advances in Drug Safety is 20420986, 20420994. ISSN stands for International Standard Serial Number.

An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.

Table Setting

Therapeutic Advances in Drug Safety Rank and SCImago Journal Rank (SJR)


The overall rank of Therapeutic Advances in Drug Safety is 4195. According to SCImago Journal Rank (SJR), this journal is ranked 1.035. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.

SJR of Therapeutic Advances in Drug Safety by Year


Year SJR
2023/2024 Coming Soon
2023 1.035
2022 0.715
2021 0.837
2020 1.196
2019 1.072
2018 1.131
2017 1.494
2016 1.702
2015 1.451
2014 0.360

Ranking of Therapeutic Advances in Drug Safety by Year


Year Ranking
2023/2024 Coming Soon
2023 4195
2022 6937
2021 5370
2020 3323
2019 3883
2018 3635
2017 2320
2016 1896
2015 2540
2014 11477

Therapeutic Advances in Drug Safety Publisher


Table Setting

Therapeutic Advances in Drug Safety is published by SAGE Publications Ltd. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2010-2023. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.


Call For Papers


Visit the official website of the journal/conference to check the further details about the call for papers.


Abbreviation


The IS0 4 standard abbreviation of Therapeutic Advances in Drug Safety is Ther. Adv. Drug Saf.. This abbreviation ('Ther. Adv. Drug Saf.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.

ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.


How to publish in Therapeutic Advances in Drug Safety


If your research field is/are related to Pharmacology (medical) (Q1), then please visit the official website of this journal.


Acceptance Rate


The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.

  • The demand or interest of researchers/scientists in publishing in a specific Journal/Conference.
  • Peer review complexity and timeline.
  • The mix of unsolicited and invited submissions.
  • The time it takes from manuscript submission to final publication.
  • And Many More.

It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.

The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.



Frequently Asked Questions (FAQs)


What's the latest impact IF of the Therapeutic Advances in Drug Safety?

Therapeutic Advances in Drug Safety latest impact IF is 3.07. It's evaluated in the year 2023. The highest and the lowest impact IF or impact score of this journal are 5.77 (2016) and 1.06 (2014), respectively, in the last 10 years. Moreover, its average IS is 3.27 in the previous 10 years.


What's the SCImago Journal Rank (SJR) of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety has an SJR (SCImago Journal Rank) of 1.035, according to the latest data. It is computed in the year 2024. In the past 10 years, this journal has recorded a range of SJR, with the highest being 1.702 in 2016 and the lowest being 0.360 in 2014. Furthermore, the average SJR of the Therapeutic Advances in Drug Safety over the previous 10-year period stands at 3.27.


What's the latest h-index of the Therapeutic Advances in Drug Safety?

The latest h-index of the Therapeutic Advances in Drug Safety is 46.


Who's the publisher of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety is published by the SAGE Publications Ltd, with its country of publication being the United Kingdom.


What's the current ranking of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety is currently ranked 4195 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 10 years, this journal has experienced varying rankings, reaching its highest position of 1896 in 2016 and its lowest position of 11477 in 2014.


What's the abbreviation or short name for the Therapeutic Advances in Drug Safety?

The standard ISO4 abbreviation for the Therapeutic Advances in Drug Safety is Ther. Adv. Drug Saf..


Is the "Therapeutic Advances in Drug Safety" classified as a Journal, Conference and Proceedings, Trade Journal or Book Series?

Therapeutic Advances in Drug Safety is classified as a journal that the SAGE Publications Ltd publishes.


What's the scope or major areas of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety encompasses the following areas:

  • Pharmacology (medical)

For a more comprehensive understanding of its scope, check the official website of this journal.


What's the ISSN of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety is assigned the following International Standard Serial Numbers (ISSN): 20420986, 20420994.


What's the best quartile of the Therapeutic Advances in Drug Safety?

The best quartile for the Therapeutic Advances in Drug Safety is Q1 (2023).


What's the coverage history of the Therapeutic Advances in Drug Safety?

The Therapeutic Advances in Drug Safety coverage history can be summarized as follows: 2010-2023.


Credits and Sources


  • Scimago Journal & Country Rank (SJR), https://www.scimagojr.com/
  • Journal Impact Factor, https://clarivate.com/



Impact Score, h-Index, and Other Important Details of These Journals, Conferences, and Books


Journal/Conference/Workshop/Book Title Type Ranking Publisher h-index Impact Score
Entrepreneurship Theory and Practice journal 220 Wiley-Blackwell 198 15.69
Child and Family Social Work journal 8089 Wiley-Blackwell Publishing Ltd 75 2.10
International Journal of Research and Method in Education journal 5876 Taylor and Francis Ltd. 38 2.50
Educational Measurement: Issues and Practice journal 5979 Wiley-Blackwell Publishing Ltd 64 1.67
Proceedings of the Royal Society of Queensland journal 21886 Royal Society of Queensland 12 0.00
Proceedings of the ACM SIGKDD International Conference on Knowledge Discovery and Data Mining conference and proceedings 4334 192 0.00
Contemporanea journal 24588 Societa Editrice Il Mulino 6 0.25
Asian Nursing Research journal 6945 Korean Society of Nursing Science 40 2.28
Integrative Psychological and Behavioral Science journal 13495 Springer New York 42 1.41
Expert Review of Obstetrics and Gynecology journal 17060 Expert Reviews Ltd. 21 0.00

Check complete list




Year wise Impact Score (IS) of Therapeutic Advances in Drug Safety

Impact Score Table

Year Impact Score (IS)
2024/2025 Coming Soon
2023 3.07
2022 3.48
2021 2.71
2020 3.39
2019 3.33
2018 2.76
2017 2.56
2016 5.77
2015 4.59
2014 1.06



Top Journals/Conferences in Pharmacology (medical)

Drug Resistance Updates
Churchill Livingstone | United States

Pharmacology and Therapeutics
Elsevier Inc. | United States

Alimentary Pharmacology and Therapeutics
Wiley-Blackwell Publishing Ltd | United Kingdom

American Journal of Transplantation
Elsevier B.V. | Netherlands

Journal of Biomedical Science
BioMed Central Ltd | United Kingdom

Drugs
Adis International Ltd | United Kingdom

npj Breast Cancer
Nature Publishing Group | United Kingdom

npj Vaccines
Nature Publishing Group | United Kingdom

Clinical Pharmacology and Therapeutics
Wiley-Blackwell | United States

Acta Pharmacologica Sinica
Nature Publishing Group | United Kingdom

See All